首页> 外国专利> Telmisartan, optionally in the form of pharmacologically acceptable salts and Amlodipine, optionally in the form of pharmacologically acceptable salts, in particular Amlodipine besylate

Telmisartan, optionally in the form of pharmacologically acceptable salts and Amlodipine, optionally in the form of pharmacologically acceptable salts, in particular Amlodipine besylate

机译:替米沙坦,可选地以药理学上可接受的盐的形式和氨氯地平,可选地以药理学上可接受的盐的形式,特别是苯磺酸氨氯地平

摘要

1-Biphenylylmethyl-benzimidazole derivs. of formula (I) and their salts are new. (A) where: R1 = F, Cl, Br, 1-4C alkyl, cycloalkyl, CH2F, CHF2 or CF3 and is in the 4 position; R2 = R2 or may also be R2 when R4 = 1H-tetrazolyl; R'2 = 3-5C alkoxy substd. in the 3, 4 or 5 position by imidazolyl, or 2-5C alkoxy substd. in the 2, 3, 4 or 5 position by benzimidazolyl or tetrahydrobenzimidazolyl; R2 = e.g. (a) 2-(1-imadazolyl)ethoxy, 1-4C alkylsulphonyloxy, OSO2Ph or phenylalkylsulphonyloxy; (b) acylamino opt. N-substd. by 1-6C alkyl, Ph, cycloalkyl, phenylalkyl, cycloalkylalkyl, bicyclohexyl or biphenylyl, where acyl is 1-7C alkanoyl, 2-4C alkoxycarbonyl, 1-6C alkylsulphonyl, benzoyl, phenylsulphonyl, phenylalkylsulphonyl, naphthylsulphonyl, cycloalkylcarbonyl, phenylalkanoyl or cycloalkylalkanoyl, where phenyl rings are opt. substd. by 1-2 of F, Cl, Br, Me and OMe, or 3-oxopyridazylinyl or (l) 3-oxodihydropyridazinyl, opt. 2-substd. by alkyl or phenylalkyl and opt. further C-substd. by 1-2 alkyl gps., Het = a C- or imino-bonded 5-membered heteroaromatic ring or a C-bonded 6-membered heteroaromatic ring. (B) where: R1 = H or F, Cl, Br, 1-4C alkyl, CH2F, CHF2 or CF3 in the 5, 6 or 7 position; R2 = Het or a gp. as defined in (l) above; R3 and R4 are as defined in (A); provided that: (a) R2 is not 3-methylimidazo (4,5-b)pyridin-2-yl or 3-n-hexylimidazo(4,5-b) pyridin-2-yl in the 6 position when R1 = H, R3 = n-Pr and R4 = COOH; (b) R2 is not benzoxazol-2-yl in the 5 or 6 position when R1 = H, R3 = n-Pr or n-Bu and R4 = 1H-tetrazolyl; (c) R2 is not 1-methyl-2-benzimidazolyl in the 5 or 6 position or 1-n-butyl-2-benzimidazolyl, 1,5-dimethyl-2-benzimidazolyl or 1-methyl-5-trifluoromethyl -2-benzimidazolyl in the 6 postion when R1 = H, R3 = n-Pr and R4 = COOH; (d) R2 is not 1-methyl-2-benzimidazolyl in the 6 position when R1 = H, R3 = n-Bu and R4 = COOH or 1H-tetrazolyl; (e) R2 is not 2-benzimidazolyl in the 6 position when R1 = H, R3 = n-Bu and R4 = COOH; unless otherwise stated, alkanoyl, alkyl and alkoxy gps. are 1-3C and cycloalkyl gps. are 3-7C.
机译:1-联苯基甲基-苯并咪唑衍生物。式(I)的化合物及其盐是新的。 (A)其中:R1 = F,Cl,Br,1-4C烷基,环烷基,CH2F,CHF2或CF3,且位于4位; R2 = R2,或者当R4 = 1H-四唑基时也可以是R2; R′2 = 3-5C烷氧基取代。在3、4或5位被咪唑基或2-5C烷氧基取代。在2、3、4或5位上被苯并咪唑基或四氢苯并咪唑基; R 2 =例如(a)2-(1-咪唑基)乙氧基,1-4C烷基磺酰氧基,OSO2Ph或苯基烷基磺酰氧基; (b)酰基氨基。 N-取代1-6C烷基,Ph,环烷基,苯基烷基,环烷基烷基,二环己基或联苯基,其中酰基为1-7C烷酰基,2-4C烷氧羰基,1-6C烷基磺酰基,苯甲酰基,苯磺酰基,苯基烷基磺酰基,萘基磺酰基,环烷基羰基,苯基烷酰基或苯环是可选的。取代选择F,Cl,Br,Me和OMe的1-2或3-氧代吡喃并基或(l)3-氧代二氢哒嗪基。 2减。通过烷基或苯基烷基和选择。进一步的C替代。 1-2烷基gps。,Het = C或亚氨基键合的5元杂芳族环或C键合的6元杂芳族环。 (B)其中:R1 = H或F,Cl,Br,1-4C烷基,CH2F,CHF2或CF3在5、6或7位; R2 = Het或gp。如上文(l)所定义; R3和R4如(A)中所定义;前提是:(a)当R1 = H时,R2在6位上不是3-甲基咪唑并(4,5-b)吡啶-2-基或3-正己咪唑并(4,5-b)吡啶-2-基,R3 = n-Pr,R4 = COOH; (b)当R1 = H,R3 = n-Pr或n-Bu且R4 = 1H-四唑基时,R2在5或6位不是苯并恶唑-2-基; (c)R2在5或6位不是1-甲基-2-苯并咪唑基或1-n-丁基-2-苯并咪唑基,1,5-二甲基-2-苯并咪唑基或1-甲基-5-三氟甲基-2-当R1 = H,R3 = n-Pr且R4 = COOH时,苯并咪唑基在6位。 (d)当R1 = H,R3 = n-Bu且R4 = COOH或1H-四唑基时,R2在6位不是1-甲基-2-苯并咪唑基; (e)当R1 = H,R3 = n-Bu和R4 = COOH时,R2在6位不是2-苯并咪唑基;除非另有说明,否则为烷酰基,烷基和烷氧基gps。是1-3C和环烷基gps。是3-7C。

著录项

  • 公开/公告号LU91802I2

    专利类型

  • 公开/公告日2011-05-30

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM PHARMA GMBH & CO KG;

    申请/专利号LU20110091802C

  • 发明设计人

    申请日2011-03-29

  • 分类号A61K31/415;A61K31/4184;A61K31/425;A61K31/435;A61K31/495;A61K31/496;A61K31/50;A61K31/505;A61P1/04;A61P9;A61P9/08;A61P9/10;A61P9/12;A61P13/02;A61P15;A61P25;A61P27/02;A61P43;C07D235/02;C07D235/08;C07D235/20;C07D401/04;C07D401/14;C07D403/04;C07D403/10;C07D403/12;C07D403/14;C07D417/04;C07D417/14;C07D471/04;C07D487/04;C07D513/04;C07D521;

  • 国家 LU

  • 入库时间 2022-08-21 18:05:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号